Growth Metrics

GoodRx Holdings (GDRX) Shares Outstanding (Diluted Average) (2020 - 2026)

GoodRx Holdings' Shares Outstanding (Diluted Average) history spans 6 years, with the latest figure at $357.0 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) fell 8.98% to $357.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $357.0 million, a 8.98% decrease, with the full-year FY2025 number at $357.0 million, down 8.98% from a year prior.
  • Shares Outstanding (Diluted Average) hit $357.0 million in Q4 2025 for GoodRx Holdings, up from $347.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for GDRX hit a ceiling of $416.4 million in Q3 2023 and a floor of $347.8 million in Q3 2025.
  • Historically, Shares Outstanding (Diluted Average) has averaged $393.7 million across 5 years, with a median of $401.1 million in 2021.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 49.25% in 2021 and later fell 10.47% in 2025.
  • Tracing GDRX's Shares Outstanding (Diluted Average) over 5 years: stood at $410.0 million in 2021, then increased by 0.7% to $412.9 million in 2022, then fell by 0.62% to $410.3 million in 2023, then dropped by 4.42% to $392.2 million in 2024, then dropped by 8.98% to $357.0 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for GDRX at $357.0 million in Q4 2025, $347.8 million in Q3 2025, and $357.2 million in Q2 2025.